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Fat, ﬁbre and cancer risk in African Americans
and rural Africans
Stephen J.D. O’Keefe1, Jia V. Li2, Leo Lahti3,4, Junhai Ou1, Franck Carbonero5,w, Khaled Mohammed1,
Joram M. Posma2, James Kinross2, Elaine Wahl1, Elizabeth Ruder6, Kishore Vipperla1, Vasudevan Naidoo7,
Lungile Mtshali7, Sebastian Tims3, Philippe G.B. Puylaert3, James DeLany8, Alyssa Krasinskas9,
Ann C. Beneﬁel5, Hatem O. Kaseb1, Keith Newton7, Jeremy K. Nicholson2, Willem M. de Vos3,4,10,
H. Rex Gaskins5 & Erwin G. Zoetendal3
Rates of colon cancer are much higher in African Americans (65:100,000) than in rural South
Africans (o5:100,000). The higher rates are associated with higher animal protein and fat,
and lower ﬁbre consumption, higher colonic secondary bile acids, lower colonic short-chain
fatty acid quantities and higher mucosal proliferative biomarkers of cancer risk in otherwise
healthy middle-aged volunteers. Here we investigate further the role of fat and ﬁbre in this
association. We performed 2-week food exchanges in subjects from the same populations,
where African Americans were fed a high-ﬁbre, low-fat African-style diet and rural Africans a
high-fat, low-ﬁbre western-style diet, under close supervision. In comparison with their usual
diets, the food changes resulted in remarkable reciprocal changes in mucosal biomarkers of
cancer risk and in aspects of the microbiota and metabolome known to affect cancer risk, best
illustrated by increased saccharolytic fermentation and butyrogenesis, and suppressed
secondary bile acid synthesis in the African Americans.
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I
n the west, colon cancer is the second leading cause of cancer
death. It afﬂictsB150,000 Americans, 250,000 Europeans and
1 million people worldwide annually. Nearly one third will
die1. Colonoscopy has permitted early detection and recent
studies have shown this to be associated with a reduction in
mortality rates, but overall impact has been small, particularly
among African Americans who shoulder the greatest burden of
the disease in the United States. Colon cancer is one of the
westernized diseases, with an incidence in Americans of African
descent of 65:100,000 compared with o5:100,000 in rural
Africans. Migrant studies, such as those in Japanese Hawaiians,
have demonstrated that it only takes one generation for the
immigrant population to assume the colon cancer incidence of
the host western population2. Although the change in diet is most
probably responsible for this3, migration changes many other
aspects of the environment. For example, cigarettes, chemicals,
infections and antibiotics might be equally responsible for the
change in colon cancer risk. To focus on the importance of diet in
African Americans and to explore the hypothesis that colon
cancer risk is determined by the inﬂuence of the diet on the
microbiota to produce anti- or pro-neoplastic metabolites, we
have performed a series of investigations between African
Americans and rural South Africans4,5. First, we observed that
their diets were fundamentally different in preparation, cooking
and composition. Animal protein and fat intake was two to three
times higher in Americans, whereas carbohydrate and ﬁbre,
chieﬂy in the form of resistant starch, were higher in Africans. On
colonoscopy, African Americans had more polyps and higher
rates of mucosal proliferation, measured by Ki67 epithelial cell
staining, conﬁrming its potential use as a biomarker of cancer
risk6. These differences were shown to be associated with
profound differences in the microbiota (Americans dominated
by genus Bacteroides and Africans by the genus Prevotella) and
metabolic phenotype. Notable differences included higher levels
of starch degraders, carbohydrate fermenters and butyrate
producers and their metabolites in Africans, and higher levels
of potentially pathogenic proteobacteria (Escherichia and
Acinetobacter) and bile acid deconjugators and their products
in Americans5. As there is extensive experimental evidence that
the products of ﬁbre fermentation, in particular butyrate, are
anti-inﬂammatory and anti-neoplastic7–9, and that the products
of bacterial bile acid conjugation, secondary bile acids,
are carcinogenic10, these ﬁndings suggested two potential
mechanisms for diet-associated cancer risk: the protective effect
of dietary ﬁbre in increasing butyrogenesis and the promotional
effect of dietary fat on stimulating bile acid synthesis by the liver.
We know from the results of two recently published human
studies that modiﬁcations of the ﬁbre and fat content of the diets
have a major impact on the colonic microbiota within a few
days11,12. Here we provide critical information on the functional
signiﬁcance of these microbiota changes on the colonic mucosa
by switching the fat and ﬁbre proportions of the diet in our two
high and low colon cancer risk study populations. Employing the
study design outlined on Table 1, we showed the anticipated
increase in saccharolytic fermentation and butyrogenesis, and
suppression of secondary bile acid synthesis produced by
switching African Americans to a high-ﬁbre, low-fat diet for
2 weeks, were associated with a signiﬁcant reduction in colonic
mucosal inﬂammation and proliferation biomarkers of cancer
risk. In stark contrast, the diet switch in rural Africans to a high-
fat, low-ﬁbre diet resulted in reverse changes in all these
parameters.
Results
Changes in the colonic mucosa following diet switch.
Measurements made in the home environment (HE) conﬁrmed
our preceding studies that the dietary intakes were quite different,
with animal protein and fat intake being two to three times higher
in Americans and ﬁbre intake, chieﬂy in the form of resistant
starch, being higher in Africans4 (Supplementary Fig. 1 and
Supplementary Tables 1–3). On colonoscopy, adenomatous
polyps were found and removed in nine Americans and no
Africans. Measurements of mucosal epithelial proliferation rates
by Ki67 staining of biopsies from ascending, transverse and
descending colon, all showed signiﬁcantly higher levels in African
Americans than in Africans (Fig. 1 and Supplementary Fig. 2),
again supporting its use as a biomarker of cancer risk. The dietary
switch was well tolerated by both populations and body weights
were all maintained with 2 kg. Remarkably, the switch decreased
proliferative rates in African Americans to levels lower than those
of Africans at baseline, whereas rates increased in Africans to
levels greater than African Americans at baseline (Fig. 1).
In tandem, histological (Supplementary Tables 5a–d) and
immunohistochemical markers of inﬂammation (Fig. 1b,c)
used, namely CD3þ intraepithelial lymphocytes and CD68þ
lamina propria macrophages, increased on switching Africans
to the high-fat diet and decreased in Americans given the high-
ﬁbre diet, thus parallelling the measured changes in mucosal
proliferation.
Changes in colonic microbial metabolism following diet
switch. The reciprocal changes in mucosal proliferation and
inﬂammation between Africans and Americans were associated
with reciprocal changes in speciﬁc microbes and their metabolites
that support our hypothesis that the mechanism whereby diet
Table 1 | Study design, time schedule and sampling.
HE study DI
(at home) (in-house)
Day 0 7 14 15 22 29
Period ED 1 HE 1 HE 2 DI 1 DI 2 ED 2
Fecal samples X X X X X X
Colonic evacuates X X
Breath H2, CH4 X X X X X X
Bloods X X
Mucosal biopsies X X
Dietary observations XXX X X X X X X X X X X X X X X
DI, dietary intervention periods; ED 1, initial endoscopy days; ED 2, ﬁnal endoscopy days; HE, home environment.
The Xs corresponding to dietary evaluation indicate the frequency of dietary recordings: three days during the home environment when consuming their usual diets, and daily during the dietary
intervention.
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affects colon cancer risk is mediated by the microbiota. First,
there was strong evidence that butyrogenesis was associated with
lower mucosal proliferation, both in Africans consuming their
usual high-ﬁbre diet and in African Americans switched to a
high-ﬁbre African-style diet (Figs 1 and 2, and Supplementary
Table 6). As a wide variety of microbes have the capacity to
produce butyrate, we targeted our analysis on the measurement of
microbial genes encoding the ﬁnal enzyme in butyrogenesis,
namely butyryl-coenzyme-A-CoA transferase13. On their usual
diet, Africans had signiﬁcantly greater abundances of butyrate
synthesizing genes, and higher fecal butyrate concentrations
(Fig. 2) and colonic evacuate quantities (Supplementary Table 7),
whereas switching them to a western, low-ﬁbre diet suppressed
each of these parameters. Reciprocally, our measurements of
butyrogenesis were lower in Americans consuming their usual
low-ﬁbre diet and increased after dietary switch to a high-ﬁbre
African-style diet. Impressively, ‘Africanization’ of the diet
increased total quantities of butyrate in colonic evacuates 2.5
times, whereas ‘westernization’ reduced quantities by half.
Recognizing that butyrogenesis is a ﬁnal common pathway of
ﬁbre fermentation, which can only be accomplished by multiple
microbial metabolic interactions, we examined the simultaneous
changes in the group of microbes that remove the major
metabolic end product, hydrogen. If hydrogen is allowed to
accumulate, it impairs the regeneration of oxidized pyridine
nucleotides, which in turn inhibit the fermentation process
and butyrogenesis14. The efﬁcient removal of hydrogen by the
hydrogenotrophic microbes, methanogens, which bind hydrogen
into non-toxic methane, sulfate-reducers, which incorporate
hydrogen into hydrogen sulﬁde, and acetogens, which consume
hydrogen to produce acetate and water, is therefore a prerequisite
for enhanced butyrogenesis. Our observation that all these
microbial groups were indeed in greater abundance, as were
their metabolic products, both in Africans consuming their usual
high-ﬁbre diet and when Americans were switched to the high-
ﬁbre diet (Fig. 2) well illustrates the importance of microbial
partnership in the maintenance of colonic health.
Flint and colleagues15 have provided strong evidence that the
most active butyrate producers, for example, Roseburia spp.
and Eubacterium rectale and Faecalibacterium prausnitzii are
contained within Clostridium groups IV and XIVa. As Africans
and African Americans have very distinct microbiota
composition at baseline (Supplementary Table 8), we performed
a global analysis of the microbiota by 16S ribosomal RNA gene
phylogenetic microarray (Human Intestinal Tract Chip
(HITChip)) to examine whether these groups were more
prevalent with high ﬁbre consumption16. Remarkably, these
groups were no more apparent in Africans or Americans eating a
high-ﬁbre diet. In fact, the compositional changes that were
speciﬁcally associated to the diet switch were minor (ten genus-
like groups for Africans and two for Americans; Fig. 3a). These
observations suggest either dissociation between structure and
function or a change in microbial interactions within the
community17. On the other hand, we observed stronger co-
occurrence patterns between the genus-level taxa in Africans
consuming their usual high-ﬁbre diet (Fig. 3b), which included
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Figure 1 | Colonic mucosal immunohistochemistry of proliferative and inﬂammatory biomarkers. Immunohistochemical analysis of colonic mucosal
biopsies taken at colonoscopy with their associated quantitative analysis on the right panel. (a) An illustration of the paired changes in Ki67 staining of
epithelial crypt cells in one African American (the ﬁrst and second panels) and one rural African (the third and 4th panels left to right) before and after
dietary switch. (b) Paired changes in CD3þ staining, similar to a. (c) Paired changes in CD68þ macrophages in the lamina propria. The bar graphs on the
far right summarize the group mean±s.e. results in 20 African Americans and 12 rural Africans. The two-tailed Mann–Whitney U-test was used for
comparisons for non-paired samples and the Wilcoxon rank sum test for paired samples, with Bonferroni correction for multivariate comparisons. Triangles
indicate signiﬁcant (Po0.05) baseline differences and stars indicate signiﬁcant changes induced by diet switch.
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Figure 2 | Targeted Analysis of microbial functional genes of speciﬁc interest and their metabolites. Box plots with whiskers and outliers summarizing the
results for the targeted functional quantitative PCR analysis of microbial genes of interest (a) and measurements of their metabolic products in fecal samples
(b) in 20 African American (AA) and 20 rural Africans (NA) at sequential time points during the study. Group median and variability outside the upper and
lower quartiles are shown. Measurements were taken before (Table 1: ED1, HE1 and HE2), during (DI1 and DI2) and after (ED2) 2 weeks of dietary change.
With regard to the functional gene analysis, bcoA codes for the enzyme butyryl-CoA:acetate CoA-transferase, which is responsible for the last step in butyrate
synthesis,mcrA for the enzyme responsible for methanogenesis, baiCD for the 7-a-dehydroxylating enzyme responsible for secondary bile acid production, and
tpA for taurine:pyruvate aminotransferase. LCA, lithocholic acid; CA, cholic acid; DCA, deoxycholic acid. As data were not normally distributed, the Kruskal–
Wallis test was used to evaluate the signiﬁcance of the group median differences across the different time points shown on the box plots. In the upper panel,
comparison with baseline ED1, ‘a’ signiﬁes no signiﬁcant change and ‘b’ a signiﬁcant change. In the lower panel for the short-chain fatty acids acetate,
propionate and butyrate, and the secondary bile acids LCA and DCA, and primary bile acid CA, there were no signiﬁcant differences between time points ED1,
HE1 and HE2, while ED2 was consistently different (Po0.05, for details, see Supplementary Table 6). This, together with Supplementary Fig. 6, illustrates no
signiﬁcant effect from colonoscopy and a profound effect from the dietary change.
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these potential butyrate producers, for example, E. rectale et rel.
and Clostridium symbiosum et rel., and bacteria associated with
complex carbohydrate utilization, for example, Oscillospira
guillermondii et rel. Reduction in ﬁbre consumption led to
opposite associations (Fig. 3b, bottom right). Reciprocally,
high-ﬁbre feeding in Americans was associated with a shift
from correlations between Bacteroides and potential butyrate-
producing groups (Roseburia intestinalis et rel. and C. symbiosum
et rel.) towards stronger co-occurrence patterns including
Firmicutes that are typically associated with complex
carbohydrate fermentation (Fig. 3b, top right).
Global changes in the metabonome following diet switch.
We have described metabonomics and the associated term,
metabolomics, as the multiparametric metabolic responses of
complex systems to perturbations through time18. Speciﬁcally,
metabonomics addresses such phenotypic changes at the level of
small-molecule metabolites and maps these processes using
appropriate analytical and statistical processes. Recognizing the
extreme complexity of the microbiota and its ability to produce a
wide array of other metabolites that could affect mucosal health,
we performed compositional and pathway analysis19 on fecal
water and urine samples by 1H NMR (Figs 4 and 5). Perhaps one
of the most striking ﬁndings of this study was the dramatically
higher quantities and diversity of metabolites in fecal water in
Africans consuming their usual diet compared with African
Americans (Fig. 4a). Although the higher levels of products of
saccharolytic fermentation were expected from our targeted
analysis, the higher quantities of proteolytic fermentation
products were not. The only signiﬁcantly more abundant fecal
metabolite identiﬁed in the Americans at baseline, and in
Africans after westernization of their diets, was choline. This is
highly signiﬁcant, as recent studies have shown that choline is
extensively metabolized by the microbiota to trimethylamine20
that is absorbed and metabolized by the liver to trimethylamine-
N-oxide, which is strongly atherogenic21, providing yet another
link between westernized diets, the microbiota and westernized
diseases. Evidence that this metabolic pathway was indeed
stimulated in Africans given the western diet was the observed
increase in urine trimethylamine-N-oxide (Table 2). Reciprocal
changes in urinary metabolites derived from microbial
metabolism of green vegetables, for example,, N-acetyl-S-
methyl-L-cysteine sulfoxide, were also observed following diet
switch, suggesting that some of the reduction in mucosal
proliferation in Americans could also have been related to the
effects of increased phytochemical consumption in the
Africanized diets22. The urinary spectra obtained from African
Americans following the change to a high-ﬁbre diet also revealed
a marked increase in an unrecoginized metabolite (Fig. 4a, left
upper panel), possibly a nicotinamide breakdown product, whose
character and function have yet to be determined.
The dietary intervention caused, in tandem with the microbiota
changes, substantial modiﬁcations in the metabolic phenotypes of
both groups (Table 2, Fig. 4a), with Africans demonstrating less
metabolic variation and Americans becoming more diverse. This
is probably best appreciated from the metabolic pathway analysis
(Fig. 5b,c) of stool and urine samples from both groups, with
colour coding identifying the signiﬁcant baseline differences,
based on integration of the enzymes of bacterial groups identiﬁed
by HITChip microarray16, host metabolic enzymes, and fecal and
urinary metabolites by 1H NMR associated with reactions from
the Kyoto Encyclopaedia of Genes and Genomes (KEGG)
database. The lower two panels illustrate the signiﬁcant shifts in
metabolic pathways identiﬁed in fecal samples after dietary
switch, showing mirror image changes reﬂecting the above, most
notably involving reductions in short-chain fatty acids and
increases in glycosylated proteins and choline metabolism in
Africans, and the unexpected increases in amino acid metabolism
in Americans. Consistent with the results of our targeted analyses,
the effects on saccharolytic fermentation were reciprocal, with
increases in acetate and lactate in Americans and reductions in
Africans. Unlike the results obtained from targeted gas
chromatography shown of Fig. 2, the increases in butyrate and
propionate measured by global 1H NMR spectroscopy did not
achieve statistical signiﬁcance, probably possibly due to sample
preparation differences between GC and NMR. Again, contrary to
expectation, fecal concentrations of colonic branched-chain
amino acids, which are likely to be derived from proteolytic
fermentation, decreased in Africans given the high-protein
western diet for unclear reasons.
Global microbe–metabolite associations. To investigate this, we
performed a partial correlation analysis between genus-level
microbes and urine and fecal metabolites (Fig. 4b), adjusted for
nationality and diet. Although we cannot biologically explain all
associations (for example, propionate correlates with enter-
obacteriaceae and Streptococcus, which are not known to produce
propionate), one striking feature was that the metabolite butyrate
was exclusively associated with microbial groups that are known
to contain butyrate producers, well exempliﬁed by R. intestinalis
et rel, E. rectale et rel and C. symbiosum et rel, which are shown in
the co-occurrence networks in Fig. 3b, to be enhanced when high-
ﬁbre diets were consumed by both population groups.
High-fat, low-ﬁbre diets and toxic microbial metabolites. It is
unlikely that butyrogenesis can alone explain diet-associated
cancer risk. Our preceding studies had shown that the higher-fat
diet of African Americans was associated with a greater
abundance of fecal microbial genes that encode for one of the key
enzymes responsible for deconjugation of bile acids (the baiCD
gene encodes for the 7a-dehydroxylating enzyme23) as well as
their metabolic products, secondary bile acids5. Secondary bile
acids have been shown to be carcinogenic in experimental models
and multiple human studies have shown that their fecal levels
are associated with cancer risk10,24,25. Furthermore, there is
substantial experimental evidence that the carcinogenic potential
of these metabolites is potentiated by colonic butyrate
deﬁciency26–29. Once again, we show that there were reciprocal
changes in both baiCD gene abundance and the secondary bile
acids, lithocholic and deoxcholic acid, after diet switch, with levels
increasing in Africans given the high-fat, western-style diet and
reductions in Americans fed the low-fat, traditional African diet
(Fig. 2, lower panel). Although the use of these functional
genes may not cover all the enzymatic pathways of interest, they
do provide legitimate tracers for them30. Remarkably,
Africanization reduced colonic evacuate secondary bile acids by
70% and westernization increased them by 400% (Supplementary
Table 7).
Dietary fat may inﬂuence colon cancer risk through other
pathways as illustrated by a recent study in an Il10 / mouse
model, which showed that a high-fat diet cultivated an increase in
the abundance of Biophila wadsworthia, a member of the
Desulfovibrionaceae family, which generates hydrogen sulﬁde
via taurine respiration, leading to acute inﬂammation31.
Exogenous hydrogen sulﬁde is a potent genotoxin in vitro32.
Finally, although no strong evidence has yet been found to indict
a speciﬁc microbe in colonic carcinogenesis, a recent study
found that Fusobacterium nucleatum was enriched in human
colon cancer tissue, and suggested that the microbe might
promote colorectal neoplasia progression through recruitment
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Figure 3 | The impact of diet switch on microbiota composition and co-occurrence networks. (a) An overview of signiﬁcantly altered genus-like
bacterial groups (FDRo0.2; linear model) following the 14-day diet change. Average fraction of total HITChip signal (proxy for relative abundance) over
the samples for each comparison. Black and grey squares indicate the average abundances at home- and intervention diet, respectively. (b) The
microbiota genus-like group co-occurrence networks of Africans and African Americans under both dietary regimens for genus-like groups. Groups with
correlation differences 41 before and after the diet and at least |r|40.5 are shown. Positive correlations are indicated with green lines; negative
correlations with red lines. Identically coloured nodes indicate network modules with three or more co-occurring groups. Grey nodes represent modules of
less than three co-occurring groups or those not represented by a module. The sample sizes are 20 African Americans and 17 rural (Native) Africans.
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of proinﬂammatory tumour-inﬁltrating immune cells33.
Alternatively, members of our group have hypothesized that
fusobacteria may promote genotoxity by their ability to convert
cysteine to hydrogen sulﬁde34. Figure 2 (upper panel) shows that
the presence and activity of both of these microbes may have
played a role in the changes in mucosal biomarkers: the high-
ﬁbre, low-fat dietary intervention in African Americans was
associated with a signiﬁcant decrease of B. wadsworthia, whereas
the low-ﬁbre, high-fat intervention in Africans was associated
with an increase of F. nucleatum.
Discussion
We have shown in individuals from high-risk and from low-risk
cancer populations that changes in the food content of ﬁbre and
fat had remarkable effects on their colonic microbiota and
metabonome within 2 weeks, and, critically, that these changes
were associated with signiﬁcant changes in mucosal inﬂammation
and proliferation. Although we cannot claim from our results that
these changes in mucosa will result in changes in the development
of cancer, there is good experimental evidence that increased
epithelial proliferation predicts neoplastic change, because it
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Figure 4 | The impact of diet switch on fecal and urinary metabolites and their correlation with fecal microbiota. (a) 1H NMR fecal and urinary spectra
obtained from African Americans (AA) and native Africans (NA) during the home environment period (HE) and post dietary intervention (DI). Metabolites
distinguishing the two groups are labelled either above the line (higher after dietary intervention) or below (higher in home environment), and the colour
represents the correlation coefﬁcient (r2) of the metabolite with the groups. (b) Two-way clustered heatmap of partial correlation between phylotypes
assigned to genus-level taxa whose representation in the fecal microbiota (x axis) of African American (AA) and rural Africans (NA), and relative
metabolite concentrations in urine and feces (y axis). P-values from correlation were adjusted for multiple testing using the Benjamini–Hochberg FDR.
Given a large number of tests performed, a cutoff value of 0.3 was used to deﬁne the signiﬁcance denoted by ‘þ ’. This level follows the Food and Drug
Administration guidelines for bioanalytical biomarkers and was chosen because of the relatively low number of samples it allows for less false negatives.
Fecal metabolites (upper compartment) demonstrated a higher number of signiﬁcant correlations with fecal microbiota compared with urinary metabolites
(lower compartment). E. rectale et rel., Lachnospira pectinoschiza et rel., R. intestinalis et rel. and Lactobacillus bovis et rel. correlate strongly with butyrate,
acetate and formate. Adjustments were made for country (binary vector with 0¼AA and 1¼NA) and diet/stage (0¼HE 2 and 1¼DI 2, see Table 2) in
calculating the partial correlations).
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increases the risk of development of DNA mutations due to the
higher rate of exposure of sensitive proliferating cells to luminal
carcinogens. The evidence for the use of proliferation biomarkers
in humans is based on the known increase in the percentage
of epithelial cells engaged in DNA synthesis (measured as
‘proliferation index’) in all premalignant conditions of the
gastrointestinal tract, as well as the observed expansion of the
proliferative zone, causing a shift of the proliferating cells from
the base to the surface of the crypt35–37. There is also substantial
evidence that chronic inﬂammation increases cancer risk38 and it
has been observed in human studies that colon cancer is increased
ﬁvefold in patients with chronic ulcerative colitis38 and reduced
50% by anti-inﬂammatory drugs39. In keeping with this, it was
noteworthy that our two biomarkers on mucosal inﬂammation,
(All)
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Pathways
Metabolites Higher after African diet
Tricarboxylic acid (TCA) cycle
Coenzyme A metabolism Purine and pyrimidine metabolism
TCA anaplerotic metabolism Aromatic and indole compounds
Glycolysis and amino sugar metabolism
Higher in African home environmentHigher after African-American diet
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Higher in urine after African-American diet, higher in faeces after African diet
Figure 5 | The impact of diet switch on fecal and urinary metabolic reaction networks. (a–c) Metabolic reaction networks of metabolites found
differentially expressed between different dietary comparisons, created using the MetaboNetworks software19 using information from the Kyoto
Encyclopaedia of Genes and Genomes (KEGG) on the reactions and enzymes within the biological system. The network shows links between metabolites if
the reaction entry in KEGG indicates a main reactant pair and the reaction is either mediated by (1) an enzyme linked to human genes, (2) an enzyme linked
to genes from identiﬁed bacterial groups using the HITChip or (3) it is part of a spontaneous process. The colour of the metabolites indicate whether the
metabolite is found in higher concentrations in the urine/feces of individuals consuming an African diet (orange), higher in individuals consuming an
African American diet (blue), higher in the African American home environment (light red), higher in the African home environment (green) or whether the
metabolites is not signiﬁcantly associated with any comparison but is part of the metabolic network (white). Two metabolites (alanine and formate) are
found with opposite associations in feces and urine (Table 2), these are therefore represented with a grey background colour. A table with full names for
each of the abbreviated metabolite names can be found in Supplementary Table 11. The background shading indicates different interconnected pathways.
In the top part of the legend, the colour for each pathway, as represented in the ﬁgure, is shown. The bottom part of the legend, with black boxes around
text box, indicates the association of each metabolite. (a) Global network of changes (‘All’) observed in fecal water and urine, and in any comparison
of the different groups. (b) Network of fecal metabolites found differentially expressed in African Americans before and after the dietary switch (‘AA’).
(c) Network of fecal metabolites found differentially expressed in Africans before and after the dietary switch (‘NA’).
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Table 2 | Fecal and urinary metabolites.
(a) Fecal
metabolites
Chemical shift
(1H p.p.m.)
HE African American
(N¼ 15) versus African
(N¼ 19)
DI African American
(N¼ 14) versus African
(N¼ 20)
African American HE
(N¼ 15) versus DI
(N¼ 14)
African HE (N¼ 19)
versus DI (N¼ 20)
Q2Y¼0.59; R2X¼ 29.8% Q2Y¼0.74; R2X¼ 26.8% Q2Y¼0.66; R2X¼ 37.2% Q2Y¼0.37; R2X¼ 30.7%
r P q r P q r P q r P q
Valine 0.99 0.77* o0.001 0.002 0.82w o0.001 0.003
Leucine 0.97 0.75* o0.001 0.003 0.75w 0.001 0.02
Isoleucine 1.01 0.78* o0.001 0.001 0.77w o0.001 0.01
Glutamate 2.36 0.82w o0.001 o0.001 0.84w o0.001 o0.001
Alanine 1.48 0.7* 0.003 0.007 0.79w o0.001 0.009
Glycine 3.57 0.72* 0.002 0.005 0.82w o0.001 0.002
Tyrosine 6.91 0.74* o0.001 0.003 0.81w o0.001 0.001
Butyrate 0.89 0.67* 0.007 0.01 0.71* o0.001 0.006
Propionate 1.06 0.75* o0.001 0.002 0.71* o0.001 0.006
Valerate 1.29 0.73* 0.001 0.004 0.66* 0.005 0.01
Acetate 1.93 0.74* o0.001 0.003 0.7w 0.03 0.006 0.75* o0.001 0.005
Lactate 1.34 0.75* o0.001 0.002 0.77w o0.001 0.009
Formate 8.45 0.69* 0.002 0.009
Choline 3.20 0.78y o0.001 0.001 0.668 0.006 0.01
Uracil 5.81 0.78* o0.001 0.001
Hypoxanthine 8.21 0.74* o0.001 0.003 0.69* 0.002 0.008
6-Aminosalicylic
acid8
7.01 0.85w o0.001 o0.001 0.77w o0.001 0.005
Fumarate 6.53 0.69* 0.002 0.008
Phenylacetate 3.54 0.81* o0.001 o0.001
b-Xylose 4.58 0.72* o0.001 0.006
b-Arabinose 4.53 0.74* o0.001 0.005
Nicotinate 8.62 0.71* o0.001 0.005
Threonine 4.26 0.77* o0.001 0.002
(b) Urinary
metabolites
Chemical
shift (1H
p.p.m.)
HE African American
(N¼ 8) versus African
(N¼ 12)
DI African American
(N¼ 7) versus African
(N¼ 12)
African American HE
(N¼8) versus DI
(N¼ 7)
African HE (N¼ 12) versus
DI (N¼ 12)
Q2Y¼0.41; R2X¼ 26.6% Q2Y¼0.86; R2X¼ 36.4% Q2Y¼0.51; R2X¼ 20.8% Q2Y¼0.83; R2X¼ 27.8%
r P q r P q r P q r P q
N-acetyl S-methyl-L-
cysteine sulfoxidez
2.78 0.8* 0.003 0.16 0.93w o0.001 o0.001 0.93w o0.001 0.03 0.8* o0.001 0.007
3-Methylthiopyruvic
acid sulfoxidez
2.81 0.81* 0.002 0.14 0.94w o0.001 o0.001 0.95w o0.001 0.009 0.77* o0.001 0.008
3-Methylthiolactic
acid sulfoxidez
2.76 0.88w o0.001 o0.001 0.83w 0.002 0.12 0.79* 0.001 0.01
S-methyl-L-cysteine
sulfoxide
2.84 0.84w 0.003 0.13
p-Cresyl sulfate 2.35 0.7* 0.03 0.28
Phenylacetylglutamine 2.27 0.71* 0.02 0.26
3-Hydroxyisovalerate 1.27 0.78y 0.005 0.18 0.858 o0.001 0.004
2-Methylpropan-2-olz 1.14 0.91w o0.001 o0.001 0.89w o0.001 0.07
Alanine 1.49 0.88 0.003 0.02 0.75y 0.03 0.33
Valine 0.99 0.858 o0.001 0.003
Isoleucine 0.93 0.888 o0.001 o0.001
Carnitine 3.23 0.888 o0.001 0.001 0.918 o0.001 o0.001
O-acetylcarnitinez 2.15 0.918 o0.001 o0.001 0.918 o0.001 o0.001
N6-acetyllysinez 1.99 0.9w o0.001 0.01
Citrate 2.53 0.85w o0.001 0.003 0.71w 0.04 0.39 0.71* 0.006 0.04
Creatine 3.94 0.738 0.004 0.03
Creatinine 4.07 0.82w 0.001 0.01 0.77* o0.001 0.007
Trigonelline 4.44 0.9w o0.001 o0.001 0.86w 0.002 0.12
4-Hydroxyhippurate 6.97 0.81w 0.003 0.02
3-Hydroxymandelate 6.92 0.87w o0.001 0.002
Dimethylamine 2.73 0.88* o0.001 0.07 0.79w 0.01 0.25 0.78* 0.001 0.01
Trimethylamine-N-
oxide
3.27 0.768 0.02 0.07
Choline 3.23 0.848 o0.001 0.004
Formate 8.46 0.798 0.002 0.01
N-methyl-2-pyridone-
5-carboxamidez
6.66 0.938 o0.001 o0.001
DI, dietary intervention; HE, home environment.
Parts (a) and (b) show signiﬁcantly changed fecal and urinary metabolites in each pairwise comparison (for example, African American versus African during HE, African American at HE versusDI).
Representative chemical shift of each metabolite is provided. The r-values are Pearson’s correlation coefﬁcient from the correlation of the metabolite concentrations with classiﬁcation (for example,
African Americans versus Native Africans). P- and q-values represent the signiﬁcance of the metabolite changes and false discovery rate-adjusted P-values76, respectively.
*Higher in HE: Africans.
wHigher in dietary switch: African Americans.
zTentative assignment.
yHigher levels of metabolites in HE: African Americans.
8Higher in dietary switch: Africans.
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CD3þ intraepithelial lymphocytes and CD68þ lamina propria
macrophages responded in the same direction as our Ki67
proliferative biomarker. CD3þ intraepithelial lymphocytes
provide a measure of T-cell activation and, therefore, the
pivotal balance between immune activation and quiescence in
response to luminal antigens, such as bacteria40,41, whereas
CD68þ lamina propria macrophages play an active role in
the persistence of chronic inﬂammation42 and neoplastic
progression43,44. Interestingly, the microbial metabolite,
butyrate, was shown recently to reduce the responsiveness of
lamina propria macrophages to commensal bacteria45, suggesting
that the dietary change in Americans may have resulted in a
decrease in both macrophage numbers and their activity.
Our study revealed two unanticipated colonic mucosal ﬁndings
in rural Africans consuming their usual baseline diets. First,
despite the signiﬁcantly lower epithelial proliferation and
population colon cancer rates, mucosal inﬂammation detected
endoscopically, histologically and by immunohistochemistry was
more common and pronounced compared with high-risk African
Americans (Fig. 1). Second, despite the lower protein intake and
lower plasma amino acid levels (Supplementary Table 9),
proteolytic fermentation was also increased, releasing metabolites
that are known to be inﬂammatory and pro-carcinogenic46. The
explanation for these ﬁndings is unclear, but may be linked to the
high prevalence of chronic parasitic infestations in rural Africans
causing inﬂammation and exudation of mucinous proteins. Of
note, schistosoma were incidentally identiﬁed in two subjects
and a tapeworm segment in another (Supplementary Fig. 3).
Intestinal protozoa have been hypothesized to stimulate
immunosurveillance against colon cancer47. Clearly, further
focused investigations of these paradoxical ﬁndings are needed,
but possible explanations involve the complex associations
between inﬂammation, immunosurveillance and carcinogenesis,
and the ability of butyrogenesis to arrest the progression
of inﬂammation to neoplasia. In murine models, lymphocytes
can suppress carcinogenesis as part of the process of
immunosurveillance, and in patients with tumours, speciﬁc
intra-tumour lymphocyte markers for Th1 polarization, and
cytotoxic and memory T cells have been shown to suppress
growth and metastasis, a process termed immunoediting48,49.
Furthermore, T-cell inﬁltration may suppress or enhance
tumorigenesis, depending on the type, density and location of
the immune cells. There is substantial experimental evidence,
recently reviewed by us7,8, that the major products of
saccharolytic fermentation, acetate, propionate and butyrate
have potent anti-neoplastic properties50, but butyrate is unique
in its maintenance of colonic mucosal health and defense. First, it
is the preferred energy source for colonocytes51. Second, it has a
remarkably wide variety of antineoplastic properties, best
exempliﬁed by its function as a histone deacetylase inhibitor52,
its capacity to downregulate the key canonical Wnt-signalling
pathway linked to colonic carcinogenesis53 and its ability to
reduce the burden of carcinogens, such as bile acids28,29,54 and
red meat products26. Further studies are needed to explore the
intriguing possibility that increased saccharolytic fermentation
and butyrogenesis may counter the recognized proliferative
properties of T-helper type 17 T cells55.
Although we have focused on the potential for a high-ﬁbre and
high-fat diet to modify metabolic pathways that have been shown
experimentally to have an impact on mucosal biomarkers of
cancer risk, it must be stressed that a change in one aspect of an
otherwise isocaloric diet will inevitably result in a change in
another. Consequently, the associated change in animal protein
or digestible carbohydrate might also be responsible for the
observed mucosal changes. Be that as it may, our results provide
fairly substantial evidence for a powerful inﬂuence of butyrate on
mucosal health and raise hope that an increase in ﬁbre
consumption, together with a moderation in fat intake, may
reduce the disproportionately high incidence of colon cancer in
African Americans and indeed in most westernized communities.
Clearly, these suggestions now need to be conﬁrmed by
longitudinal studies. With regard to ﬁbre, total quantities may
be critical, as ﬁbre supplementation at E35 g per day has
generally failed to reduce polyp recurrence in clinical trials56 and
recent experimental studies demonstrate that a threshold effect
of butyrate availability determines its inhibitory effect on
proliferation52. Furthermore, human studies by Burkitt57
concluded that total ﬁbre intake needs to exceed 50 g per day
(as in our study) to prevent colon cancer. Our results also raise
serious concern that the progressive westernization of African
communities may reduce butyrogenesis, allowing their high basal
state of chronic inﬂammation to progress through proliferation to
neoplasia38, culminating in the emergence of colon cancer as a
major health issue58.
Methods
Study design. First, the study was submitted to the University of Pittsburgh and
University of KwaZulu-Natal Institutional Review Boards for approval. We
employed a unique design (Table 1 and Supplementary Note 1), where 20 healthy
middle-aged African Americans and 20 rural Africans (Supplementary Tables 10:
Demographics) from the same communities previously studied5 were studied ﬁrst
for 2 weeks in their own HE, eating their usual food (HE study), and then again in-
house while they were fed the intervention diet for 2 weeks (dietery intervention)
study). Consequently, each subject served as his/her own control, which is
important given the known wide individual variation in colonic microbiota
composition. We chose intervention diets that were at the same time palatable and
contained reverse quantities of ﬁbre and fat, such that African Americans would be
given ‘African style’ foods increasing their average ﬁbre intake from 14 to 55 g per
day and reducing their fat from 35% to 16% of total calories, whereas Africans were
given a ‘western-style’ diet reducing their ﬁbre from 66 to 12 g per day and
increasing their fat from 16% to 52% (Supplementary Tables 1–3). Cogniscient of
the problems of compliance to acute dietary change and the accuracy of dietary
recall to estimate actual intakes within the community, we elected to perform all
the dietary intervention studies in-house, where meals could be prepared and given
under close supervision. With African Americans, participants were housed the
University of Pittsburgh Clinical Translational Research Center, and with rural
Africans we employed in a rural lodging facility, close to their homes, with full
kitchen facilities. Body weights were maintained within 2 kg by adjusting food
quantities while keeping the overall macronutrient composition the same. The
sampling schedule is given on Table 1, showing that fresh fecal samples were taken
at three intervals during the HE study and again three times after the diet switch.
Colonoscopy was performed to identify latent disease, polyps, or cancer, to obtain
3 h colonic evacuates for analysis and biopsies for biomarkers of cancer risk4 at the
beginning of the HE study and end of the dietery intervention study. Full details of
the menus, cooking methods and total dietary compositions are given under
Supplementary Tables 2, 3 and 4a–c, and Supplementary Note 2).
Subjects and recruitment. Age- and sex-matched healthy volunteers, with the age
range 50–65 years, were randomly selected from the African American population
in the Pittsburgh region of Pennsylvania and from the rural native South Africans
from the rural Kwazulu region. We collaborated with Dr Stephen Thomas, Director
of Minority Studies at the University of Pittsburgh School of Public Health, to
recruit healthy African American volunteers from the Pittsburgh region, and also
advertised the study with the approval of our Institutional Review Board in public
areas. In South Africa, volunteers were be recruited through advertisements placed
in public community centres, for example, post ofﬁces, town halls, civic centres and
through the iZulu Community Health Center. Appropriate compensation (as
advised by Minority studies and the iZulu Community and ratiﬁed by the Uni-
versity of Pittsburgh and KwaZulu-Natal) for time and testing was paid to
volunteers for participation.
Screening. Informed signed consent was taken from each participant. All African
volunteers could understand English, but a nurse-translator participated in the
consent process to ensure proper understanding of the details of the research
procedures. Screening was performed in Pittsburgh at the Clinical Translational
Research Center and in Africa at Ngwelezana Hospital outpatient clinic, Empan-
geni, KwaZulu-Natal, South Africa. A detailed medical history was ﬁrst taken. With
rural Africans, a local bilingual nurse acted as an interpreter. A 20-ml blood sample
was taken for full blood count, ESR, electrolytes and urea, albumin, alkaline
phosphatase, AST and bilirubin. If the results were normal and if they satisﬁed the
eligibility criteria, they were invited to participate in the study.
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Subject eligibility. Details are given under Supplementary Note 1. Inclusion
criteria were as follows: healthy volunteers, from GI standpoint between 40 and
65 years (age at which colon cancer screening/colonoscopy is recommended in this
population) and body mass index between 18 and 35 kgm 2 (Supplementary
Discussion). Exclusion criteria were as follows: participants pre-colonoscopy were
ineligible if they had a history of familial adenomatous polyposis, hereditary non-
polyposis colorectal cancer, inﬂammatory bowel disease or invasive cancer within
5 years before enrollment (h/o adenomatous polyps acceptable). In addition,
ineligible participants were individuals with known renal, hepatic or bleeding
disorders; previous GI surgery resulting in disturbed gut function due to of loss of
bowel or altered anatomy, or any form of chronic GI disease resulting in disturbed
gut function, diarrhoea and malabsorption; and individuals with antibiotic use
within the past 12 weeks (Supplementary Discussion), current steroids use or
with diabetes. Exclusion criteria post colonoscopy were detection of previously
unrecognized ulceration (with depth and 40.5 cm), stricture, severe inﬂammation
and polyps 41 cm diameter or cancer.
Fecal, colonic and mucosal sampling and colonoscopy. To synchronize the
measurements of the microbiota, the metabolome and the colonic mucosa, the
sampling was tied to the preparation for and conduct of a colonoscopy, as pre-
viously described4, at baseline while on their usual diet (ED1, Table 1), and then
again at the conclusion of the dietary change (ED2, Table 1). In this, fresh fecal
samples are collected before colonic evacuation and immediately frozen at  80 C
and the total colonic contents are collected for 3 h during evacuation with a simple
polyethylene glycol solution. In this, 2 l of polyethylene glycol (60 g l 1, average
molecular weight 3350 g/mol) solution was consumed rapidly as possible over 30
min. We avoided using the commercial preparation ‘Golytely’, as it contains
sodium sulfate, which is known to disturb the microbiota composition. Our
experience had shown that the quality of bowel preparation with this technique was
similar to the more conventional overnight bowel washout. The mucosa health
status was assessed by visualization and biopsy. Polyps, when encountered, were
removed per standard practice and biopsies were taken from normal mucosa from
the proximal (caecum/ascending colon), mid (transverse) and distal (sigmoid)
colon at 25 cm from the anal verge. Mucosal samples for immunohistochemistry
were collected in formalized saline and for gene expression in RNAlater (Qiagen,
Germantown, MD) before being stored at  80 C.
Measurement of mucosal biomarkers. Histology. Colonic mucosal biopsies were
obtained by colonoscopy before and after dietary switch from three different sites
(ascending, transverse and descending) and stored in 10% buffered formalin. Later,
the biopsy samples were embedded in parafﬁn and 5-mm sections were cut and
stained with either routine haematoxylin and eosin (H&E) or immunohisto-
chemical stains (see below). The histologic ﬁndings on the H&E-stained sections
were evaluated by one blinded, experienced gastroenterological histopathologist
(AK). Measurements focused on the numbers of inﬂammatory cells and eosino-
phils in the lamina propria and the numbers of intraepithelial lymphocytes. Scoring
of the H&E-stained section was done as shown in Supplementary Table 5a. Any
pathologic ﬁnding, such as the presence of parasitic organisms, was recorded.
Immunohistochemistry. Slides for CD3 and Ki67 staining were deparafﬁnized at
60 C for 2 h. To inhibit endogenous peroxidase, the slides were pre-treated using
3% hydrogen peroxide/methanol at room temperature (RT) for 10min, followed by
antigen retrieval with 0.2% pepsin solution (P7012, Sigma, 3050 Spruce St, St Louis,
MO, USA) at 37 C for 10min. Serum Free Protein Block (X0909, Dako, 6392 Via
Real, Carpinteria, CA 93013, USA) was used at RT for 10min. The slides were
drained and incubated with primary antibodies CD3 and Ki67 (A0452, 1:100,
rabbit polyclonal, Dako; MIB-1, 1:100, mouse monoclonal, Dako), respectively, at
RT for 1 h. Secondary detection was applied using Immpress universal antibody
Polymer detection kit (MP-7500, Vector Labs, 30 Ingold Road, Burlingame, CA
94010, USA) at RT for 30min. The slides were stained with DAB substrate kit (SK-
4100, Vector Labs) for 10min and counter stained using Shandon Hematoxylin
(6765015, Thermo Scientiﬁc, 81 Wyman St, Waltham, MA 02451, USA).
Slide staining for CD68 was done on a Ventana Benchmark Ultra slide stainer.
Deparafﬁnized slides were pretreated using the ultra CC1 (950-224, Ventana, 1910
Innovation Park Dr, Tucson, AZ 85755, USA) for 24min for antigen retrieval.
Slides were incubated with the primary antibody CD68 (M087601, 1:100, mouse
monoclonal, Clone PG-M1, Dako,) for 32min RT. The Optivew DAB kit (760-700,
Ventana) was used for secondary detection.
Quantiﬁcation of immunohistochemical staining. Counting of the proportions
of positive staining cells using light microscopy at  400 magniﬁcation was
performed by a single investigator (KM), under blinded conditions. To assess
inter-observer variability, 40 slides were randomly selected and recounted by a
second senior pathologist (AK), showing a concurrence of 88% for Ki67þ and
80% for CD68þ densities.
Ki67. The proportion of Ki67-positive staining cells were counted in well-oriented
crypts (average/slide 8, range 4–14). Ki67 proliferation rate was deﬁned as the
number of Ki67þ cells divided by the total number of crypt cells and were
expressed as percentage. The differences were found to be the same in the total
crypt and in the upper crypt; hence, only the total crypt proportions are reported here.
CD3. Only CD3þ staining intraepithelial lymphocytes were counted in a repre-
sentative area of at least 300 epithelial cells. The density of intraepithelial lym-
phocytes was expressed as an index of number of CD3-positive lymphocytes per
100 epithelial cells.
CD68. The number of CD68-positive cells (macrophages) within the lamina
propria were counted and graded on a scale from 1 to 3: grade 1 (none/rare), grade
2 (scattered superﬁcial collections) and grade 3 (strong, diffuse or band-like
inﬁltrate in the superﬁcial lamina propria) as shown in Fig. 1c.
Targeted analysis of fecal and colonic microbes and metabolites of special
interest. Details of the materials and methods used for the collection, preparation
and analysis of fecal samples for targeted analysis of microbes of special interest
(real-time quantitative PCR) and their metabolites (Agilent Technologies 6890N
Network GC System with a ﬂame-ionization detector for short-chain fatty acids
and Shimadzu HPLC–mass spectrometry for quantiﬁcation using electrospray
ionization in negative ion mode by monitoring the (M–H) ion for bile acids) in
African Americans and rural Africans have been previously published5.
Justiﬁcation for the use of the BcoA functional gene for butyrate production is that
Flint’s group in Aberdeen have demonstrated that although there are a number of
different metabolic pathways that use different enzymes that culminate in butyrate
synthesis, butyryl-CoA:acetate CoA-transferase, the product of the BcoA gene, is
responsible for the last step in butyrate synthesis in the vast majority of intestinal
butyrate producers13. Similarly, there are other microbial enzymes that participate
in bile acid deconjugation, but Wells et al.23 demonstrated that there was a good
correlation between human fecal bacterial dehydroxylating activity measured by
fecal dilution assay and their PCR assay for the baiCD gene, which encodes the key
enzyme responsible for the bile acid 7a-dehydroxylation pathway.
Plasma amino acids. Fasting blood concentrations were measured in extracted
plasma by reverse-phase C-18 precolumn derivatization HPLC (AccQTag Ultra
derivatization, Waters, Milford, MA) as previously described5.
Statistical analysis. Statistical analysis of the group differences in continuous
variables was conducted using SPSS 16.0 (SPSS Inc.). The signiﬁcance of group
differences for normally distributed data was assessed with unpaired and paired
Student’s t-tests. The non-parametric data were analysed with a Mann–Whitney
U-test or Kruskal–Wallis one-way analysis of variance (ANOVA) by ranks for
unpaired data and Wilcoxon signed-rank tests for paired data. The signiﬁcance of
the association was evaluated with Spearman’s rank correlation test. A level of
Po0.05 was accepted as statistically signiﬁcant. Data are presented as means±s.e.
Complex microbiota and metabonome data were analysed by several multivariate
ordinations detailed below (principal component analyses and non-metric multi-
dimensional scaling), Kruskal–Wallis independent tests and multivariate ANOVA
with Bonferroni correction.
Global analysis of the microbiota composition and diversity. We chose
the HITChip phylogenetic microarray for the global proﬁling of microbiota
composition. It has been demonstrated that the HITChip analysis of fecal samples
provides highly concordant results concerning the microbiota composition when
compared with 16S rRNA gene or metagenome sequencing59–62, as it allows deep
proﬁling of phylotypes at high resolution, down to o0.1% relative abundance,
corresponding to a duplicated set of 100,000 pyrosequencing reads per sample with
very high reproducibility (498%)59 and at considerably lower cost.
HITChip analysis. DNA was isolated from fecal or colonic samples and
subsequently used for phylogenetic proﬁling of the intestinal microbiota using the
HITChip phylogenetic microarray16. Standardized quality control was maintained
through our library of a duplicated set of 3,631 probes targeting the 16S rRNA gene
sequences of over 1,000 intestinal bacterial phylotypes. Brieﬂy, the full-length 16S
rRNA genes were ampliﬁed, and PCR products were transcribed in vitro into RNA,
labelled with Cy3 and Cy5, and fragmented. Hybridizations were performed in
duplicate and data were extracted from microarray-scanned images using Agilent
Feature Extraction software, version 10.7.3.1 (http://www.agilent.com). Array
normalization was performed as previously described, using a set of custom R
scripts (http://r-project.org) and stored in a custom MySQL database (http://
www.mysql.com). Duplicate hybridizations with a Pearson correlation 498%
were considered for further analysis. Microbiota proﬁles were generated by pre-
processing the probe-level measurements with minimum–maximum normalization
and the frozen Robust Probabilistic Averaging probe summarization62,63 into three
phylogenetic levels: level 1, deﬁned as order-like 16S rRNA gene sequence groups;
level 2, deﬁned as genus-like 16S rRNA gene sequence groups (sequence similarity
490%); and level 3, phylotype-like 16S rRNA gene sequence groups (sequence
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similarity498%). In the present work, we primarily focus on the genus-level (level
2) variation. Signiﬁcance of the differences between the time points (Fig. 3a) were
estimated based on a (paired) linear model for microarrays (limma) with the
threshold of false discovery rate (FDR)o0.2 estimated based on Benjamini–
Hochberg procedure and a minimum fold change of 25% (0.1 at the Log10 scale)64.
Microbial co-occurrence network analysis. We constructed the co-occurrence
networks between the 130 genus-like bacterial groups based on their logarithmic
abundances (HITChip log10 signal) within each treatment group (African
Americans and Native Africans; before and after the dietary intervention). For a
robust correlation analysis, we applied the SparCC algorithm using 20 iterations
and with 50 bootstrap data sets for signiﬁcance testing, followed by q-value65
correction of the pseudo P-values from the bootstrap analysis. We focused on the
signiﬁcant (|r|40.5; qo0.01) correlations between the genus-like groups where a
qualitative change (change of sign) in the correlation was observed following the
dietary intervention. To ensure robust analysis, we included only the correlations
that changed drastically in the intervention, with a difference of 41 between the
correlation values before and after intervention (so that the correlations would
change for instance from  0.5 to 0.5, or higher). This provided a list of genus-like
bacteria that had signiﬁcant changes in their mutual correlation networks following
the dietary intervention in either rural African or African American group. To
simplify interpretation, we clustered the associated genus-like groups into coherent
network modules with complete-linkage hierarchical clustering based on the
SparCC correlations. We deﬁned a module as a connected sub-network where the
correlations between all genus-like groups within the module are r40.5. Networks
were visualized using the network visualization and exploration platform Gephi66.
The resulting modules are highlighted in Fig. 3b.
Global analysis of the metabolome: sample preparation for NMR spectro-
scopic analysis. All urinary samples were thawed at RT and vortexed for 10 s.
A total of 400 ml of urinary sample was thoroughly mixed with 250ml of 0.2M
sodium phosphate buffer containing 20% D2O, pH 7.4, 0.01% 3-(trimethylsilyl)-
[2,2,3,3-2H4]propionic acid sodium salt and 3mM sodium azide (NaN3). The
mixture was subsequently centrifuged at 10,000g for 10min and 600 ml of super-
natant was transferred into an NMR tube with an outer diameter of 5mm.
Approximately 200mg of wet fecal sample was mixed with 600 ml of H2O (HPLC
grade) in a 1.5-ml Eppendorf tube. A cycle of 30-s vortexing, 5-min sonicating
at 4 C and 30-s vortexing was then carried out on the mixture, followed by
centrifuging at 10,000g for 10min. A total of 400 ml of supernatant was added into a
1.5-ml Eppendorf tube containing 250ml of aforementioned sodium phosphate
buffer, vortexed and spun at 10,000g for 10min. An amount of 600 ml of
supernatant was put into an NMR tube.
1H NMR spectroscopy. 1H NMR spectra of urinary and fecal water extract
samples were acquired using a Bruker 600MHz spectrometer (Bruker, Rhein-
stetten, Germany) at the operating 1H frequency of 600.13MHz at a temperature of
300K. An NMR pulse sequence (recycle delay -90-t1-90-tm-90-acquisition) and
standard parameters were used to obtain standard one-dimensional 1H NMR
spectral data as described in Beckonert et al.67
Multivariate statistical data analysis. 1H NMR spectra of urine and fecal
extracts were automatically phased, referenced to 3-(trimethylsilyl)-[2,2,3,3-
2H4]propionic acid sodium salt at 1H d0.00 and baseline-corrected using an in-
house developed MATLAB script (Dr Tim Ebbels, Imperial College London). The
processed NMR spectra (1H d 0 to 10) were imported to MATLAB (R2012a,
MathWorks) and digitized into 20k data points with a resolution of 0.0005 p.p.m.
using an in-house developed script. The water peak region in urine (4.7–5.14
p.p.m.) and fecal water spectra (4.7–5.18 p.p.m.) were removed to minimize the
effect of the disordered baseline caused by water suppression. In addition, regions
(1H 0–0.3) in urine spectra and regions (1H 0–0.25) in fecal water spectra con-
taining only noise were therefore removed, together with the urea signal in urine
(1H 5.48–6.24). Because of the heavy peak shifting in urinary spectra, a recursive
segment-wise peak alignment method was applied, to improve metabolic bio-
marker recovery68. Probabilistic quotient normalization was subsequently
performed on the resulting data sets, to account for dilution of complex biological
mixtures69. Principal component analysis and orthogonal partial least-squares
discriminant analysis was carried out with a unit variance scaling method in
SIMCA (Pþ 13.0) and MATLAB software. P-values of metabolites were calculated
using ANOVA and FDR was also calculated for each metabolite marker70. For the
two-way clustered heatmap (Fig. 4b) between fecal microbiota and metabolite
concentrations in urine and feces, the partial correlation was calculated for each
phylotype and metabolite. The correlation was adjusted for country and dietary
intervention to account for baseline differences. A pFDR cutoff value of 0.3 was
used to deﬁne the signiﬁcance (denoted by ‘þ ’), to account for the different
numbers of samples in each data set. For each data set (microbiota, fecal
metabolites and urinary metabolites), the data were clustered using hierarchical
cluster analyses with complete linkage. The optimal number of clusters was chosen
as the splitting that maximized the modularity using the correlation as weight of
each edge in the network.
Metabolic reaction network generation. Using the freely available Metabo-
Networks software19 reactions that occur spontaneously or by means of enzymes
linked to human and/or bacterial genomes were identiﬁed in the KEGG. All
complete genome sequences listed in KEGG that could be associated to the
bacterial groups represented on the HITChip were included in creating the
database, resulting in a total of 817 bacterial genomes included in the database.
Next, the software was used to construct a shortest-path metabolic reaction
network between all (fecal and urinary) metabolites signiﬁcantly different in any of
the different dietary comparisons. From this ‘global network’, two sub-graphs were
generated for each of the two dietary switches using signiﬁcantly associated fecal
metabolites. To highlight the differential expression of the metabolites associated
with speciﬁc pathways, the background shading was added to the graphs to indicate
the different interconnecting pathways (Fig. 5a–c). The abbreviations and full
names of these metabolites can be found in Supplementary Table 11.
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